• Continued growth in digital asset management services revenue, up 15.69% from previous quarter
• Received $413,773 R&D Tax Incentive from ATO
• Completed $1 million placement from sophisticated investors

333D Ltd released its cash flow report (Appendix 4C) for the quarter ending 30 September 2025 and provided an update on activities during the quarter. The Company continued to receive licence and services fees from its digital asset management contracts, generating $318,431 in cash receipts from customers, representing a 15.69% increase compared to the previous quarter. This demonstrates the value of the Company's strategic shift in providing digital asset management services to the healthcare sector. The Company also received an R&D Tax Incentive of $413,773 from the Australian Taxation Office as a result of its continuing research and development activities. During the quarter, the Company completed a placement to sophisticated investors, raising $1,000,000 in capital at an issue price of $0.10 per share, with net proceeds of $970,000. The Company's expenditure during the quarter was approximately $571,463, comprising product manufacturing and operating costs, staff costs, and administration and corporate costs. In addition to the cash balance of $835,508, the Company also holds 2.01830401 Bitcoin valued at AUD$356,784 as part of its Bitcoin Treasury Management Policy. The Company announced several key events, including a pilot collaboration agreement with BioScan 360 to provide services in the preventative healthcare market, and participation in various international conferences on Bitcoin, artificial intelligence, and digital assets.